{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:29:01Z","timestamp":1761647341792},"publisher-location":"Chichester, UK","reference-count":67,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002007.pub2","type":"reference-entry","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T10:35:41Z","timestamp":1114166141000},"source":"Crossref","is-referenced-by-count":32,"title":["Single versus combination intravenous antibiotic therapy for people with cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Heather E","family":"Elphick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton A","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"key":"10.1002\/14651858.CD002007.pub2-BIB1|cit1","series-title":"Proceedings of the 11th European Cystic Fibrosis Conference","first-page":"227","article-title":"Clinical evaluation of Carbenicillin and Sisomycin alone or in combination in CF patients with pulmonary exacerbations [abstract]","author":"Costantini","year":"1982"},{"key":"10.1002\/14651858.CD002007.pub2-BIB2|cit2","series-title":"23rd Cystic Fibrosis Club Abstracts; 1982 May 14; Washington D.C.","first-page":"124","article-title":"Therapeutic efficacy of Ticarcillin and Carbenicillin in patients with cystic fibrosis: a double blind study [abstract]","author":"Huang","year":"1982"},{"issue":"Suppl 25","key":"10.1002\/14651858.CD002007.pub2-BIB3|cit3","first-page":"162s","article-title":"Once daily Tobramycin monotherapy versus conventional antibiotic therapy for the treatment of pseudomonal pulmonary exacerbations in cystic fibrosis patients [abstract]","volume":"10","author":"Master","year":"1997","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD002007.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ppul.1060","article-title":"Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study","volume":"31","author":"Master","year":"2001","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ppul.1950040403","article-title":"Comparison of Piperacillin alone versus Piperacillin plus Tobramycin for treatment of respiratory infections in children with cystic fibrosis","volume":"4","author":"McCarty","year":"1988","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB7|cit6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/147.3.559","article-title":"Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: Ticarcillin-Tobramycin, Azlocillin-Tobramycin and Azlocillin-Placebo","volume":"147","author":"McLaughlin","year":"1983","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD002007.pub2-BIB6|cit7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/11.suppl_B.195","article-title":"Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis","volume":"11 Suppl B","author":"McLaughlin","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(77)80790-7","article-title":"Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin","volume":"90","author":"Parry","year":"1977","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002007.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365548609032319","article-title":"Immediate and prolonged clinical efficacy of Ceftazidime versus Ceftazidime plus Tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"18","author":"Pedersen","year":"1986","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3476(99)70197-6","article-title":"Comparison of a B-lactam alone versus B-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis","volume":"134","author":"Smith","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2010.09.003","article-title":"Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis","volume":"10","author":"Adeboyeku","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD002007.pub2-BIB12|cit12","first-page":"iii85","article-title":"Efficacy of once daily tobramycin for acute pulmonary exacerbations of cystic fibrosis (CF) - a microbiological perspective [abstract]","volume":"56","author":"Al-Ansari","year":"2001","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB13|cit13","first-page":"34","article-title":"Evaluation of once daily tobramycin versus the traditional three times daily for the treatment of acute pulmonary exacerbations in adult cystic fibrosis patients [abstract]","volume":"15","author":"Al Ansari","year":"2006","journal-title":"Qatar Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/dkf168","article-title":"Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis","volume":"50","author":"Aminimanizani","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD002007.pub2-BIB15|cit15","series-title":"14th Annual Meeting of the European Working Group for Cystic Fibrosis","first-page":"63","article-title":"Clinical efficacy and \"in vitro\" activity of some antibiotics, ceftazidime aztreonam or carbenicillin with aminoglycosides against Pseudomonas in Cystic fibrosis patients [abstract]","author":"Balsamo","year":"1986"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(80)80155-7","article-title":"Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?","volume":"97","author":"Beaudry","year":"1980","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002007.pub2-BIB17|cit17","series-title":"20th Annual Meeting Cystic Fibrosis Club Abstracts; 1979 May 1; Atlanta, Georgia","first-page":"1","article-title":"Is anti-pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? [abstract]","author":"Beaudry","year":"1979"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00006454-198803000-00008","article-title":"Controlled trial of aztreonam vs tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis","volume":"7","author":"Bosso","year":"1988","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-199701000-00031","article-title":"Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime\/tobramycin in the treatment of acute pulmonary exacerbations","volume":"16","author":"Church","year":"1997","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"11","key":"10.1002\/14651858.CD002007.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.52.11.987","article-title":"Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis","volume":"52","author":"Conway","year":"1997","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD002007.pub2-BIB21|cit21","series-title":"20th European Cystic Fibrosis; 1995 June 18-21; Brussels, Belgium","first-page":"P3","article-title":"A safety profile of intravenous colomycin in adult care [abstract]","author":"Conway","year":"1995"},{"key":"10.1002\/14651858.CD002007.pub2-BIB22|cit22","first-page":"296","article-title":"Colistin alone or in combination with a second antibiotic is effective in the treatment of respiratory exacerbations in cystic fibrosis [abstract]","volume":"Suppl 13","author":"Conway","year":"1996","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ppul.1950070310","article-title":"Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy","volume":"7","author":"Boeck","year":"1989","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD002007.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0300-2977(99)90113-4","article-title":"Meropenem versus ceftazidime plus tobramycin for pulmonary disease in CF patients [abstract]","volume":"54","author":"Boeck","year":"1999","journal-title":"The Netherlands Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(87)80337-2","article-title":"Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease","volume":"111","author":"Donati","year":"1987","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00006454-198503000-00012","article-title":"Controlled trial of ceftazidime vs ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis","volume":"4","author":"Gold","year":"1985","journal-title":"Pediatric Infectious Disease"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/12.2.175","article-title":"Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis","volume":"12","author":"Hoogkamp-Korstanje","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD002007.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1128\/AAC.00174-09","article-title":"Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis","volume":"53","author":"Hubert","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3476(81)80486-6","article-title":"A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis","volume":"99","author":"Hyatt","year":"1981","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3476(85)80100-1","article-title":"Comparison of cefoperazone sodium vs methicillin, ticarcillin and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis","volume":"106","author":"Jewett","year":"1985","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD002007.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"S39, Abstract n","DOI":"10.1016\/S1569-1993(09)60158-2","article-title":"Eradication of Pseudomonas aeruginosa in adults with CF [abstract]","volume":"8","author":"Kenny","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD002007.pub2-BIB32|cit32","first-page":"609","article-title":"The treatment of exacerbations of pulmonary disease in cystic fibrosis: netilmicin compared with netilmicin and carbenicillin","volume":"25","author":"Krause","year":"1979","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00003072-199202000-00002","article-title":"Aerosol scintigraphy in the assessment of therapy for cystic fibrosis","volume":"17","author":"Kuni","year":"1992","journal-title":"Clinical Nuclear Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/10.3.227","article-title":"Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis","volume":"10","author":"Levy","year":"1982","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00006454-198607000-00014","article-title":"Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis","volume":"5","author":"Jackson","year":"1986","journal-title":"Pediatric Infectious Disease"},{"key":"10.1002\/14651858.CD002007.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0022-3476(85)80264-X","article-title":"Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal","volume":"106","author":"Nelson","year":"1985","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ppul.21176","article-title":"Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas","volume":"45","author":"Noah","year":"2010","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD002007.pub2-BIB38|cit38","series-title":"9th International Cystic Fibrosis Congress; 1984 June 9-15; Brighton, England","first-page":"Poster 4.21","article-title":"Pseudomonas pulmonary infections in cystic fibrosis: Ceftazidime vs ceftazidime plus sisomicin vs piperacillin plus sisomicin [abstract]","author":"Padoan","year":"1984"},{"issue":"7","key":"10.1002\/14651858.CD002007.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00006454-198707000-00006","article-title":"Ceftazidime monotherapy vs combined therapy in Pseudomonas pulmonary infections in cystic fibrosis","volume":"6","author":"Padoan","year":"1987","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"Suppl A","key":"10.1002\/14651858.CD002007.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/12.suppl_A.313","article-title":"Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis","volume":"12","author":"Permin","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD002007.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s15010-009-8116-5","article-title":"Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"issue":"5","key":"10.1002\/14651858.CD002007.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s15010-009-8117-4","article-title":"Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"key":"10.1002\/14651858.CD002007.pub2-BIB43|cit43","first-page":"152","article-title":"Measurement of serum tobramycin in the presence of ticarcillin or piperacillin","volume":"22","author":"Roberts","year":"1992","journal-title":"Australian Journal of Hospital Pharmacy"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB45|cit44","first-page":"152","article-title":"Measurement of serum tobramycin in the presence of ticarcillin or piperacillin","volume":"22","author":"Roberts","year":"1992","journal-title":"Australian Journal of Hospital Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB44|cit45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2125.1993.tb00380.x","article-title":"An in vivo assessment of the tobramycin\/ticarcillin interaction in cystic fibrosis patients","volume":"36","author":"Roberts","year":"1993","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD002007.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/thx.40.5.358","article-title":"Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms","volume":"40","year":"1985","journal-title":"Thorax"},{"issue":"Suppl 20","key":"10.1002\/14651858.CD002007.pub2-BIB47|cit47","first-page":"284","article-title":"Pharmacokinetics of once-daily tobramycin in adult cystic fibrosis patients [abstract]","volume":"30","author":"Tsang","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"19","key":"10.1002\/14651858.CD002007.pub2-BIB48|cit48","first-page":"262","article-title":"Efficacy and safety of once daily tobramycin in treating acute respiratory exacerbations in adult patients [abstract]","volume":"28","author":"Watson","year":"1999","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD002007.pub2-BIB49|cit49","series-title":"Proceedings of the 10th International Cystic Fibrosis Congress; 1988 March 5-10; Sydney, Australia. (Excerpta Medica, Asia Pacific Congress Series, No. 74)","first-page":"13","article-title":"A double-blind comparison of ceftazidime with tobramycin and ticarcillin in the treatment of exacerbations of pseudomonas chest infection in children with cystic fibrosis [abstract]","author":"Wesley","year":"1988"},{"issue":"Suppl","key":"10.1002\/14651858.CD002007.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0300-2977(99)90103-1","article-title":"Efficacy and safety of once daily tobramycin in treating acute respiratory exacerbations in adult patients [abstract]","volume":"54","author":"Whitehead","year":"1999","journal-title":"The Netherlands Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1183\/09031936.02.00221602","article-title":"Once-daily tobramycin in the treatment of adult patients with cystic fibrosis","volume":"19","author":"Whitehead","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD002007.pub2-BIB52|cit52","first-page":"939","article-title":"Cystic fibrosis lung inflammation: early, sustained and severe","volume":"151","author":"Cantin","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9028","key":"10.1002\/14651858.CD002007.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(96)05169-0","article-title":"Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic","volume":"348","author":"Cheng","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.0.CO;2-1","article-title":"Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients","volume":"28","author":"Frederiksen","year":"1999","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD002007.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.me.44.020193.000245","article-title":"Antibiotic therapy for chronic infection of pseudomonas in the lung","volume":"44","author":"Hoiby","year":"1993","journal-title":"Annual Review of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002007.pub2-BIB57|cit57","first-page":"172","article-title":"Contralateral suppression of distortion product otoacoustic emissions in children with cystic fibrosis: effects of tobramycin","volume":"9","author":"Katbamna","year":"1998","journal-title":"Journal of the American Academy of Audiology"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1099-0496(199708)24:2<137::AID-PPUL13>3.0.CO;2-3","article-title":"Current understanding of the inflammatory process in cystic fibrosis: onset and etiology","volume":"24","author":"Konstan","year":"1997","journal-title":"Pediatric Pulmonology"},{"volume-title":"The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs","year":"1997","author":"Kucers","key":"10.1002\/14651858.CD002007.pub2-BIB59|cit59"},{"issue":"7159","key":"10.1002\/14651858.CD002007.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.317.7159.612","article-title":"Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment","volume":"317","author":"Levy","year":"1998","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD002007.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02961666","article-title":"Aminoglycoside induced ototoxicity in patients with cystic fibrosis","volume":"160","author":"Mulherin","year":"1991","journal-title":"Irish Journal of Medical Science"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD002007.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/ajrccm\/141.4_Pt_1.914","article-title":"Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone","volume":"141","author":"Regelmann","year":"1990","journal-title":"American Review of Respiratory Disease"},{"issue":"5","key":"10.1002\/14651858.CD002007.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical Evidence of Bias","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD002007.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ppul.10036","article-title":"Lack of concordance in the use and monitoring of intravenous aminoglycosides in UK cystic fibrosis centers","volume":"33","author":"Tan","year":"2002","journal-title":"Paediatric Pulmonology"},{"issue":"7","key":"10.1002\/14651858.CD002007.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0954-6111(93)90010-W","article-title":"Cystic Fibrosis: antibiotic prescribing practices in the United Kingdom and Eire","volume":"87","author":"Taylor","year":"1993","journal-title":"Respiratory Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002007.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1445-5994.1999.tb01583.x","article-title":"Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?","volume":"29","author":"Wolter","year":"1999","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"7360","key":"10.1002\/14651858.CD002007.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.325.7360.381","article-title":"Systematic reviews and lifelong diseases","volume":"325","author":"Elphick","year":"2002","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002007.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:08:09Z","timestamp":1628528889000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002007.pub2"}},"subtitle":[],"editor":[{"given":"Heather E","family":"Elphick","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":67,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002007.pub2","relation":{},"subject":[],"published":{"date-parts":[[2005,4,20]]}}}